Genasys™ Inc. Reports Fiscal Third Quarter 2020 Financial Results
SAN DIEGO, Aug. 10, 2020 (GLOBE NEWSWIRE) — Genasys Inc. (NASDAQ: GNSS), the global leader in critical communications systems and […]
Equillium Announces Positive Interim Data with Itolizumab in Acute GVHD Study
Complete response observed in five of seven patients in first two dose cohortsCOVID-19 Pre-IND meeting request and briefing package submitted […]
Calithera Biosciences Reports Second Quarter 2020 Financial Results and Recent Highlights
–Calithera to Provide Corporate Update via Conference Call and Webcast at 2:00 p.m. PT on August 10, 2020–SOUTH SAN FRANCISCO, […]
CDW Corporation Announces Upsizing and Pricing of Registered Offering of $700 Million of Senior Notes due 2029
LINCOLNSHIRE, Ill., Aug. 10, 2020 (GLOBE NEWSWIRE) — CDW Corporation (NASDAQ: CDW), a leading multi-brand technology solutions provider to business, […]
Adaptive Biotechnologies Reports Second Quarter 2020 Financial Results
SEATTLE, Aug. 10, 2020 (GLOBE NEWSWIRE) — Adaptive Biotechnologies Corporation (“Adaptive Biotechnologies”) (Nasdaq: ADPT), a commercial stage biotechnology company that […]
PDS Biotechnology Corporation Announces Proposed Public Offering of Common Stock
FLORHAM PARK, N.J., Aug. 10, 2020 (GLOBE NEWSWIRE) — PDS Biotechnology Corporation (“PDS Biotech” or the “Company”) (Nasdaq: PDSB), a […]
Sunrun Reports Second Quarter 2020 Financial Results
309,000 Customers, an increase of 21% year-over-yearNet Earning Assets of $1.6 billion, an increase of 14% year-over-yearSAN FRANCISCO, Aug. 10, […]
Rockwell Medical, Inc. Provides Second Quarter 2020 Financial and Operational Update
-Q2 2020 revenue of $15.9 million--Increase in contracted clinics of 44 percent quarter-over-quarter--Reached contracted annualized treatment volume for Triferic Dialysate […]
Pixelworks Reports Second Quarter 2020 Financial Results
Announces Restructuring to Reduce Operating Expenses by $3.2 Million AnnuallyAnticipates Additional Smartphone Wins to Drive Mobile Revenue Growth in Second […]
ChemoCentryx Reports Second Quarter 2020 Financial Results and Recent Highlights
— U.S. New Drug Application (NDA) submitted for avacopan in ANCA-associated vasculitis —— Balance sheet bolstered with $325.7 million in net […]
